Advertisement

Topics

Corindus to Report Fourth Quarter and Full Year 2017 Financial Results on March 14, 2018

16:02 EDT 13 Mar 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today announced that it will release financial and business results for the fourth quarter of 2017 after the close of tr...

Other Sources for this Article

Corindus Vascular Robotics, Inc.
Investor Relations Contact:
Lynn Pieper Lewis, 415-937-5402
ir@corindus.com
or
Media Contact:
Kate Stanton, 508-653-3335 ext. 200
Kate.stanton@corindus.com

NEXT ARTICLE

More From BioPortfolio on "Corindus to Report Fourth Quarter and Full Year 2017 Financial Results on March 14, 2018"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Vascular
Vascular relates to blood vessels (Oxford Medical Dictionary) and can be used to describe the supply of blood, a disease affecting the blood vessels or molecules associated with these structures. For example, <!--LGfEGNT2Lhm-->atherosclerosis ...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...